In mid-September, we suggested that investors take a closer look at Pfizer, the big ($211 billion market cap) pharmaceutical company. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post AMAT: Applied MaterialsNext PostThe bullish case for gold, silver and bitcoin in the long run You Might Also Like Long Term Interest Rates: TLT November 18, 2024 MJ: “Smoke Em If You Got Em” November 11, 2020 Market Commentary | SPY Update November 7, 2019
You Might Also Like Long Term Interest Rates: TLT November 18, 2024 MJ: “Smoke Em If You Got Em” November 11, 2020 Market Commentary | SPY Update November 7, 2019
